Author:
Ke Xiaoan,Wang Linjie,Zhao Yuxing,Duan Lian,Deng Kan,Yao Yong,Pan Hui,Gong Fengying,Zhu Huijuan
Funder
National High-Level Hospital Clinical Research Funding
Publisher
Springer Science and Business Media LLC
Reference55 articles.
1. B.A. Houssay, E. Anderson, Diabetogenic action of purified anterior pituitary hormones. Endocrinology 45, 627–629 (1949)
2. Y. Macotela, J. Triebel, C. Clapp, Time for a New Perspective on Prolactin in Metabolism. Trends Endocrinol. Metab. 31, 276–286 (2020)
3. C. Schmid, D.L. Goede, R.S. Hauser et al. Increased prevalence of high Body Mass Index in patients presenting with pituitary tumours: severe obesity in patients with macroprolactinoma. Swiss. Med. Wkly 136, 254–258 (2006)
4. H. Soran, J. Wilding, I. MacFarlane, Body weight and prolactinoma: a retrospective study. Int J. Obes. Relat. Metab. Disord. 28, 183 (2004)
5. R. Pelkonen, E.A. Nikkilä, B. Grahne, Serum lipids, postheparin plasma lipase activities and glucose tolerance in patients with prolactinoma. Clin. Endocrinol. 16, 383–390 (1982)
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献